Literature DB >> 22556118

Physicians' explanations for apparent gaps in the quality of rheumatology care: results from the US Medicare Physician Quality Reporting System.

Jeffrey R Curtis1, Pradeep Sharma, Tarun Arora, Aseem Bharat, Itara Barnes, Michael A Morrisey, Meredith Kilgore, Kenneth G Saag, Nicole C Wright, Huifen G Yun, Elizabeth Delzell.   

Abstract

OBJECTIVE: The metrics used to assess quality of care and pay for performance in rheumatology are increasingly important. The Centers for Medicare and Medicaid Services established the Physician Quality Reporting System (PQRS) to allow physicians to report performance measures for many conditions, including osteoporosis and rheumatoid arthritis (RA). We described the frequency and nature of physician-reported reasons why recommended care for individual osteoporosis and RA patients was not provided.
METHODS: Using national data on Medicare fee-for-service beneficiaries (2007-2009), we identified health care providers reporting on quality of care for any of 3 osteoporosis or 3 RA measures. PQRS reason codes allowed physicians to submit explanations why recommended care was not given.
RESULTS: In 2009, 1,775 physicians reported on ≥1 osteoporosis PQRS measure and 630 physicians reported on ≥1 RA measure. For the older women whose physician reported on lifetime dual x-ray absorptiometry screening at least once since the age of 60 years via PQRS, 76% received such screening. Among the patients with physician-diagnosed osteoporosis reported via PQRS, 82% received prescription osteoporosis medication in the preceding year. For RA medication use reported via PQRS, 89% of patients received a disease-modifying antirheumatic drug or a biologic agent. For the remaining 11-24% of osteoporosis and RA patients, physicians reported medical, patient, system, or other reasons why care was considered but not provided.
CONCLUSION: A substantial fraction of Medicare enrollees who did not receive recommended osteoporosis or RA care had physician-documented reasons for why care was not provided. For Medicare and other health plans that implement penalties for apparent nonperformance or delivery of suboptimal care, it will be important to allow physicians to provide reasons that care was considered medically inappropriate, refused, or otherwise not feasible.
Copyright © 2013 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2013        PMID: 22556118      PMCID: PMC3414685          DOI: 10.1002/acr.21713

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  33 in total

Review 1.  Cardiovascular risk prediction: basic concepts, current status, and future directions.

Authors:  Donald M Lloyd-Jones
Journal:  Circulation       Date:  2010-04-20       Impact factor: 29.690

2.  The use of propensity scores in pharmacoepidemiologic research.

Authors:  S M Perkins; W Tu; M G Underhill; X H Zhou; M D Murray
Journal:  Pharmacoepidemiol Drug Saf       Date:  2000-03       Impact factor: 2.890

3.  A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries.

Authors:  Jeffrey R Curtis; Archana Jain; Johan Askling; S Louis Bridges; Loreto Carmona; William Dixon; Axel Finckh; Kimme Hyrich; Jeffrey D Greenberg; Joel Kremer; Joachim Listing; Kaleb Michaud; Ted Mikuls; Nancy Shadick; Daniel H Solomon; Michael E Weinblatt; Fred Wolfe; Angela Zink
Journal:  Semin Arthritis Rheum       Date:  2010-08       Impact factor: 5.532

4.  A review of goodness of fit statistics for use in the development of logistic regression models.

Authors:  S Lemeshow; D W Hosmer
Journal:  Am J Epidemiol       Date:  1982-01       Impact factor: 4.897

5.  Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems.

Authors:  Lisa J Herrinton; Jeffrey R Curtis; Lang Chen; Liyan Liu; Elizabeth Delzell; James D Lewis; Daniel H Solomon; Marie R Griffin; Rita Ouellet-Hellstom; Timothy Beukelman; Carlos G Grijalva; Kevin Haynes; Bindee Kuriya; Joyce Lii; Ed Mitchel; Nivedita Patkar; Jeremy Rassen; Kevin L Winthrop; Parivash Nourjah; Kenneth G Saag
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-09-15       Impact factor: 2.890

6.  The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents.

Authors:  Jeffrey R Curtis; Fenglong Xie; Lang Chen; John W Baddley; Timothy Beukelman; Kenneth G Saag; Claire Spettell; Raechele M McMahan; Joaquim Fernandes; Kevin Winthrop; Elizabeth Delzell
Journal:  Ann Rheum Dis       Date:  2011-05-17       Impact factor: 19.103

Review 7.  Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

Authors:  Tim Bongartz; Alex J Sutton; Michael J Sweeting; Iain Buchan; Eric L Matteson; Victor Montori
Journal:  JAMA       Date:  2006-05-17       Impact factor: 56.272

8.  Initiation of rheumatoid arthritis treatments and the risk of serious infections.

Authors:  Carlos G Grijalva; Lisa Kaltenbach; Patrick G Arbogast; Edward F Mitchel; Marie R Griffin
Journal:  Rheumatology (Oxford)       Date:  2009-11-11       Impact factor: 7.580

9.  Confounder summary scores when comparing the effects of multiple drug exposures.

Authors:  Suzanne M Cadarette; Joshua J Gagne; Daniel H Solomon; Jeffrey N Katz; Til Stürmer
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-01       Impact factor: 2.890

10.  Evaluating medication effects outside of clinical trials: new-user designs.

Authors:  Wayne A Ray
Journal:  Am J Epidemiol       Date:  2003-11-01       Impact factor: 4.897

View more
  10 in total

1.  A Multistakeholder Approach to Improving Quality in Rheumatoid Arthritis: Proceedings from the Rheumatoid Arthritis Quality Expert Medical Panel.

Authors:  Jeffrey R Curtis; C Kent Kwoh; Albert J Rizzoli; John A Welz
Journal:  Am Health Drug Benefits       Date:  2014-11

2.  Commentary: measuring quality of care in osteoporosis.

Authors:  Stuart L Silverman; Jeffrey Curtis
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

Review 3.  Incentives in Rheumatology: the Potential Contribution of Physician Responses to Financial Incentives, Public Reporting, and Treatment Guidelines to Health Care Sustainability.

Authors:  Mark Harrison; Katherine Milbers; Tamara Mihic; Aslam H Anis
Journal:  Curr Rheumatol Rep       Date:  2016-07       Impact factor: 4.592

Review 4.  A new era of quality measurement in rheumatology: electronic clinical quality measures and national registries.

Authors:  Chris Tonner; Gabriela Schmajuk; Jinoos Yazdany
Journal:  Curr Opin Rheumatol       Date:  2017-03       Impact factor: 5.006

Review 5.  Quality Measures and Quality Improvement Initiatives in Osteoporosis-an Update.

Authors:  S French; S Choden; Gabriela Schmajuk
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

6.  Bone Mineral Density T-Scores Derived from CT Attenuation Numbers (Hounsfield Units): Clinical Utility and Correlation with Dual-energy X-ray Absorptiometry.

Authors:  Nathan R Hendrickson; Perry J Pickhardt; Alejandro Munoz Del Rio; Humberto G Rosas; Paul A Anderson
Journal:  Iowa Orthop J       Date:  2018

7.  A Randomized Trial Comparing Disease Activity Measures for the Assessment and Prediction of Response in Rheumatoid Arthritis Patients Initiating Certolizumab Pegol.

Authors:  Jeffrey R Curtis; Melvin Churchill; Alan Kivitz; Ahmed Samad; Laura Gauer; Leon Gervitz; Willem Koetse; Jeffrey Melin; Yusuf Yazici
Journal:  Arthritis Rheumatol       Date:  2015-12       Impact factor: 10.995

8.  Extraction of Rheumatoid Arthritis Disease Activity Measures From Electronic Health Records Using Automated Processing Algorithms.

Authors:  Grant W Cannon; Jorge Rojas; Andreas Reimold; Ted R Mikuls; Debra Bergman; Brian C Sauer
Journal:  ACR Open Rheumatol       Date:  2019-10-30

9.  The relationship between patients' income and education and their access to pharmacological chronic pain management: A scoping review.

Authors:  Nicole Atkins; Karim Mukhida
Journal:  Can J Pain       Date:  2022-09-01

10.  Implementation of disease activity measurement for rheumatoid arthritis patients in an academic rheumatology clinic.

Authors:  Alison Bays; Elizabeth Wahl; David I Daikh; Jinoos Yazdany; Gabriela Schmajuk
Journal:  BMC Health Serv Res       Date:  2016-08-15       Impact factor: 2.655

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.